These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3411603)

  • 21. [Studies on the antinociceptive activity of guanabenz, with particular reference to clonidine and morphine (author's transl)].
    Sakamoto H; Inoue K; Murata T; Kohno S; Ohata K
    Nihon Yakurigaku Zasshi; 1982 Feb; 79(2):85-92. PubMed ID: 7068051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the analgesic effect of centhaquin in mouse tail flick and hot-plate tests.
    Andurkar SV; Gulati A
    Pharmacology; 2011; 88(5-6):233-41. PubMed ID: 21997570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone reverses the antinociceptive action of clonidine in spontaneously hypertensive rats.
    Tchakarov L; Abbott FV; Ramirez-Gonzalez MD; Kunos G
    Brain Res; 1985 Feb; 328(1):33-40. PubMed ID: 3971179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
    Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
    Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers.
    Mastrianni JA; Ingenito AJ
    J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of opioidergic and noradrenergic mechanisms in nefopam antinociception.
    Gray AM; Nevinson MJ; Sewell RD
    Eur J Pharmacol; 1999 Jan; 365(2-3):149-57. PubMed ID: 9988097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats.
    Noble F; Soleilhac JM; Soroca-Lucas E; Turcaud S; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1992 Apr; 261(1):181-90. PubMed ID: 1560364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and pharmacological studies of 4,4-disubstituted piperidines: a new class of compounds with potent analgesic properties.
    Huegi BS; Ebnöther AM; Rissi E; Gadient F; Hauser D; Roemer D; Hill RC; Buescher HH; Petcher TJ
    J Med Chem; 1983 Jan; 26(1):42-50. PubMed ID: 6600791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose clonidine enhances pregnancy-induced analgesia to visceral but not somatic stimuli in rats.
    Iwasaki H; Collins JG; Saito Y; Uchida H; Kerman-Hinds A
    Anesth Analg; 1991 Mar; 72(3):325-9. PubMed ID: 1994761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
    Schiene K; De Vry J; Tzschentke TM
    J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
    Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
    Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the ability of yohimbine to antagonize the hypotensive effect of clonidine in normotensive and spontaneously hypertensive anesthetized rats.
    Tibirica E; Feldman J; Bousquet P
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1062-6. PubMed ID: 2855238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Objective assessment of clonidine analgesia in man and influence of naloxone.
    Porchet HC; Piletta P; Dayer P
    Life Sci; 1990; 46(14):991-8. PubMed ID: 2182959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of monoaminergic modulation to the analgesic effect of tramadol.
    Desmeules JA; Piguet V; Collart L; Dayer P
    Br J Clin Pharmacol; 1996 Jan; 41(1):7-12. PubMed ID: 8824687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of opioidergic component in the antihypertensive effect of clonidine.
    Chauhan PA; Hemavathi KG; Gulati OD
    Indian J Physiol Pharmacol; 1983; 27(4):305-10. PubMed ID: 6086521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XAMI and DCDM, agonists at cAMP-associated octopamine receptors in cockroach nerve cord, produce centrally mediated antinociception in mice.
    Raffa RB; Orr N; Connelly CD; Hollingworth RM
    Brain Res; 1991 Sep; 559(2):211-9. PubMed ID: 1686573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4-Anilidopiperidine analgesics. 2. A study of the conformational aspects of the analgesic activity of the 4-anilidopiperidines utilizing isomeric N-substituted 3-(propananilido)nortropane analogues.
    Riley TN; Bagley JR
    J Med Chem; 1979 Oct; 22(10):1167-71. PubMed ID: 513063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apparent pA2 estimates for an antinociceptive receptor.
    Parale MP; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):59-67. PubMed ID: 2862851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.